Cara Therapeutics Total Liabilities

Cara Therapeutics (CARA) currently reports a total liabilities of $11M as of March 2026. That compares with $47M in the prior-year period — down 75.9% year over year. Use the charts on this page to explore Cara Therapeutics's total liabilities history and peer comparisons.

Cara Therapeutics's total liabilities decreased from $47M to $11M — a 75.9% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Cara Therapeutics reported $11M in total liabilities as of March 2026. That compares with $47M in the prior-year period — down 75.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $11M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Cara Therapeutics, and consider following CARA for alerts when major investors trade the stock.

Cara Therapeutics is classified in the Healthcare sector. On total liabilities, it currently shows $11M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CARA with unrelated industries.